Curable Hepatitis B Virus-Related Hepatocellular Carcinoma Clinical Trial
Official title:
Investigator Initiated Study of Thymosin in HBV-related HCC
Efficacy and safety of Thymalfasin adjuvant therapy in HBV-related HCC after curative resection.
Multi-center, Randomized, Controlled Clinical Trial to Evaluate the Efficacy and Safety of Adjuvant Thymalfasin Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma After Curative Resection. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment